BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17711097)

  • 1. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A; Narojek L; Sykut-Cegielska J
    Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring of the diet for the individual in maple syrup urine disease: long-term home dietary treatment of an adult patient with MSUD by monitoring of daily intake with a personal computer. A case report.
    Lie IE; Haugstad S; Holm H
    Hum Nutr Appl Nutr; 1985 Apr; 39(2):130-6. PubMed ID: 3839494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria.
    Parsons HG; Carter RJ; Unrath M; Snyder FF
    J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E; Halvorsen S
    Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary management of maple-sirup-urine disease: extension of equivalency systems.
    Bell L; Chao E; Milne J
    J Am Diet Assoc; 1979 Mar; 74(3):357-61. PubMed ID: 762364
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine).
    Mogoş T; Cheţa CP; Mincu IT
    Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of maple syrup urine disease in Canada. Committee for improvement of Hereditary Disease Management.
    Can Med Assoc J; 1976 Nov; 115(10):1005-13. PubMed ID: 1032577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease)].
    Vulović D; Vilhar N; Hajduković R; Marjanović B; Stojanović Lj
    Srp Arh Celok Lek; 1975 May; 103(5):419-36. PubMed ID: 1188483
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on "branched chain oxoacid aciduria" (maple syrup diseases)].
    Goedde HW; Blume KG; Möhlenbeck F; Rotthauwe HW; Simon HA; Lang K
    Med Klin; 1966 Dec; 61(52):2063-7. PubMed ID: 4385693
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
    Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK
    Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of maple syrup disease. Clinical and electroencephalographic observations with dietetic experiment. Critical review of literature].
    Grossi-Bianchi ML; Gatti R; Marchi AG
    Minerva Pediatr; 1967 Aug; 19(33):1552-65. PubMed ID: 4889027
    [No Abstract]   [Full Text] [Related]  

  • 13. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
    Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
    Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of early and long-term management of classical maple syrup urine disease.
    Clow CL; Reade TM; Scriver CR
    Pediatrics; 1981 Dec; 68(6):856-62. PubMed ID: 6798541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Academy of Pediatrics. Committee on Nutrition: special diets for infants with inborn errors of amino acid metabolism.
    Pediatrics; 1976 May; 57(5):783-92. PubMed ID: 940719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical-genetic studies in maple syrup disease].
    Goedde HW; Blume KG
    Med Welt; 1968 Dec; 49():2699-703. PubMed ID: 5730703
    [No Abstract]   [Full Text] [Related]  

  • 19. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
    Skaper SD; Molden DP; Seegmiller JE
    Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine equivalency system in managing branched chain ketoaciduria.
    Smith BA; Waisman HA
    J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.